De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
BL Pharmtech Beheer
Beheer criteriumcontroles 0/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Hyo-Lim Lee
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | no data |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?
Sep 03Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S
May 21Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?
Mar 07Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years
Mar 14Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?
Jan 20Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares
Nov 28CEO
Hyo-Lim Lee
no data
Tenure
Mr. Hyo-Lim Lee serves as the Chief Executive Officer of BL Pharmtech Corp. (formerly known as NRD Co., Ltd.).